BOTTOSSO, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 290
EU - Europa 88
AS - Asia 54
Totale 432
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 290
IT - Italia 48
CN - Cina 43
FI - Finlandia 18
HK - Hong Kong 7
DE - Germania 6
GB - Regno Unito 6
SE - Svezia 4
BE - Belgio 2
FR - Francia 2
IE - Irlanda 2
IR - Iran 2
IN - India 1
MY - Malesia 1
Totale 432
Salva come PNG Salva come JPEG
Città #
Chandler 82
Ashburn 20
Beijing 20
Fairfield 19
Cambridge 16
Helsinki 15
Padova 11
San Diego 9
Wilmington 9
New York 8
Medford 7
Princeton 7
Seattle 6
Houston 5
Roxbury 5
Ann Arbor 4
London 4
Milan 4
Woodbridge 4
Codogno 3
Des Moines 3
Hamburg 3
Lappeenranta 3
Selvazzano Dentro 3
Venice 3
Brussels 2
Capo d'Orlando 2
Clermont-Ferrand 2
Dublin 2
Hong Kong 2
Legnaro 2
Los Angeles 2
Rome 2
Sale Marasino 2
Selargius 2
Sestu 2
Turin 2
Vimercate 2
Washington 2
Guangzhou 1
Gunzenhausen 1
Islington 1
Kilburn 1
Kuala Lumpur 1
Marche 1
Norwalk 1
Pune 1
Rockville 1
Tabriz 1
Tehran 1
Totale 312
Salva come PNG Salva come JPEG
Nome #
Validation of Residual Proliferative Cancer Burden as a Predictor of Long-Term Outcome Following Neoadjuvant Chemotherapy in Patients with Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer 61
Evolution of HER2-low expression from primary to recurrent breast cancer 53
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive cases 46
Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy 45
Gene-expression signatures to inform neoadjuvant treatment decision in HR+/HER2− breast cancer: Available evidence and clinical implications 42
A comprehensive profiling of the immune microenvironment of breast cancer brain metastases 35
HER2-low-positive breast cancer: evolution from primary tumor to residual disease after neoadjuvant treatment 30
Gastric metastases of breast cancer: Histopathological and molecular characterization of a single Institution case series 29
A prognostic model based on residual cancer burden and tumor-infiltrating lymphocytes on residual disease after neoadjuvant therapy in HER2+ breast cancer 23
Oligometastatic breast cancer: Dissecting the clinical and biological uniqueness of this emerging entity. Can we pursue curability? 18
Leptomeningeal metastases in patients with human epidermal growth factor receptor 2 positive breast cancer: Real-world data from a multicentric European cohort 14
HER2DX genomic test in HER2-positive/hormone receptor-positive breast cancer treated with neoadjuvant trastuzumab and pertuzumab: A correlative analysis from the PerELISA trial 13
Prognostic impact of extracranial disease control in HER2+ breast cancer-related brain metastases 13
PI3K/PTEN/mTOR pathway dynamic tracking and prognostic value in HR+/HER2- BC patients with residual disease after neoadjuvant chemotherapy: a cohort study 10
Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival 9
Cardiac Safety of Adjuvant Trastuzumab and Paclitaxel for HER2+ early breast cancer patients published in Abstract Book of the 21th National Congress of Italian Association of Medical Oncology (AIOM) 25-27 October, 2019 - Rome, Italy Abstracts 9
Radiological response of leptomeningeal metastases according to revised RANO criteria is associated with overall survival in breast cancer patients 7
Totale 457
Salva come PNG Salva come JPEG
Categoria #
all - tutte 3.952
article - articoli 3.952
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.904
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 5 0 5 5 2 10 2 0 2
2021/202285 0 0 3 4 8 8 18 3 4 5 7 25
2022/2023176 22 19 9 27 14 20 9 9 28 2 15 2
2023/2024165 15 21 17 12 23 25 25 8 6 13 0 0
Totale 457